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Hypoxemic patients with chronic obstructive pulmonary disease (COPD) are at risk of carbon
dioxide (CO2) retention during oxygen therapy and hypercapnia in COPD is associated with
an ominous prognosis. Rebreathing with oxygen mask is possible in practice and possibly
affects CO2 retention due to an increased inspired fraction of CO2. Its effects on arterial partial
pressure of CO2 during oxygen supply have, to the best of our knowledge, never been studied.
We measured the inspired fraction of CO2 in eighteen non-hypoxemic stable COPD patients
with a capnograph during a 5 min trial with two different modes of oxygen supply (oxygen mask
without reservoir bag and nasal prongs, respectively at a flow of 10 l/min and 2 l/min). We
found no significant increase in inspiratory CO2 concentration. These findings suggest that
inspired fraction of CO2 does not increase markedly during controlled oxygen therapy.
ª 2008 Published by Elsevier Ltd.Introduction
Oxygen supply is a life saving treatment and is widely used
by medical and paramedical staff. When oxygen is supplied
to Chronic Obstructive Pulmonary Disease (COPD) patients,
it might occur that carbon dioxide (CO2) retention occurs346807; fax: þ32 16346803.
z.kuleuven.be (M. Decramer).
8 Published by Elsevier Ltd.and causes a respiratory acidosis that may be fatal.1
Despite extensive research, the mechanism responsible for
hypercapnia is not completely understood and CO2 is
a major determinant of respiratory stimulation in many
COPD patients with acute respiratory failure.2 Prolonged
expiration is typically observed by COPD patients and if
expiration is prolonged, the oxygen and CO2 concentrations
Figure 1 Mean and standard deviation of inspiratory CO2
concentration for first minute and last minute for a oxygen
mask without reservoir at a flow of 10 l/min, and for first
minute and last minute for nasal prongs at a flow of 2 l/min.
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blood.3 An older study showed that some devices used to
administer oxygen therapy could cause appreciable
rebreathing.4 We hypothesized that an increased inspired
fraction of CO2 due to this rebreathing could be a possible
cause of this CO2 retention during controlled oxygen
therapy. We quantified the inspired fraction of CO2 in two
different modes of oxygen supply (oxygen mask and nasal
prongs, respectively at a flow of 10 l/min and 2 l/min)
during a 5 min trial with eighteen non-hypoxemic stable
COPD patients. To assess a possible change in CO2
concentration during the test, the CO2 concentration of the
first minute was compared with the CO2 concentration of
the last minute.
Methods
Eighteen stable patients with COPD from the Pulmonary
Rehabilitation Unit were enrolled: 78 % were men, mean
(SEM) age was 66.9 1.5 years, mean (SEM) forced
expiratory volume in 1 s was 1.17 0.35 l or 43.3 15.3 %
predicted with a mean (SEM) diffusing capacity of the
lungs for carbon monoxide of 44.7 15% predicted. Diag-
nosis of COPD was based on the GOLD (Global Initiative for
Chronic Obstructive Lung Disease) criteria: a smoking
history (>10 pack years) and a spirometry with a Tiffeneau
index< 0.7. Patients had no acute exacerbation of their
disease and no symptoms of heart failure or pneumonia at
the moment of the examination. All measurements were
done under full inhalation therapy according to the GOLD
stages but none of the patients had long-term oxygen
therapy. Pulmonary function measurements were the latest
available in the patient’s file. On average, they preceded
the examination by a mean (SEM) of 80.9 (19.5) days.
Two modes of oxygen supply were assessed: the first was
oxygen supply in an oxygen mask (without reservoir bag)
with a flow of 10 l/min, the second way was oxygen supply
via nasal prongs with a flow of 2 l/min. Two variables were
measured: oxygen concentration and carbon dioxide
concentration. This was done by calculating the mean CO2
and O2 concentration of the first and the last minute. The
subjects were asked to breathe normally in a quiet envi-
ronment during 5 min with each method of oxygen supply.
A capnograph (Normocap 200, Datex, Finland) was used
to record the gas concentrations (measured in %, with
a sampling frequency of 100 Hz). Calibration was done
before every test in which the CO2 concentration of the
ambient air was taken as base line. Respiratory rate was
calculated from the CO2 curve as the number of breathing
cycles per minute. Out of every breathing curve the
percentage of inspiratory CO2 was calculated. Data was
processed in Matlab v 7.4.0287 (the Mathworks Inc., Natick,
MA, USA). For the comparison between groups one way
analysis of variance has been used and P< 0.05, two sided
was used as the limit of statistical significance.
Results
For every patient, the mean CO2 concentration at inspiratory
levelwas calculated for the first and lastminute of the oxygen
mask. The same was done for the nasal prongs. To verify ifthere was an increase or decrease in CO2 concentration, the
ratio between the last minute and first minute was calcu-
lated. This was done for both methods of oxygen supply.
For the oxygen mask average CO2% in the first minute
was (mean SD) 0.0046 0.0021%, for the last minute
0.0037 0.0020%. For the nasal prongs average in the first
minute was 0.0044 0.0020% and in the last minute
0.0043 0.0020%. Differences were not statistically signif-
icant: PZ 0.19 for the oxygen mask and PZ 0.89 for the
nasal prongs (see Fig. 1).
Discussion
Treatment with oxygen, an available and commonly
prescribed drug, has been shown to improve long-term
survival in patients with severe chronic bronchitis and
emphysema5 but it is often difficult to adequately
oxygenate COPD patients with respiratory failure, the
major risk being to precipitate CO2 retention and signifi-
cant acidosis. Physiological studies have shown that
hyperoxia-induced hypercapnia is primarily due to
impairment in gas exchange rather than to depression of
ventilation.6,7 Another possible cause of this CO2 reten-
tion during controlled oxygen therapy could be an
increased inspired fraction of CO2. In our study, we found
first, that inspired CO2-fraction was low in all circum-
stances and second, that there was no significant increase
in inspiratory CO2 concentration after a 5 min duration
trial done by stable non-hypoxemic COPD patients when
comparing the concentrations of the inspiratory CO2 at
the first minute to those at the end of the trial, inde-
pendently of the way of oxygen supply. These findings
suggest that the risk of CO2 retention due to an increased
inspired fraction of CO2 by non-hypoxemic stable COPD
patients is low, that the ventilatory drive in our patients
was unaffected by the way of oxygen supply and that
there was no increased ventilation-perfusion mismatch-
ing. The present study may be, however, limited due to
the current limited sample and by the absence of invasive
confirmation by blood gas measurements. However,
a more detailed study is needed to confirm these results
in acutely hypoxemic or mildly hypercapnic patients to
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result in death and cardiac arrhythmias.8
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